SLC25A5 and neoplasm: utilized T cell-specific ADP/ATP translocase-2 knockout mice and melanoma mouse models to confirm that the deficiency of the mitochondrial protein Ant2 in T cells bypassed typical metabolic reprogramming, inducing an activated-like metabolic state and enhancing T cell anti-tumor immunity (35).